From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 324,118 shares, representing 0.97% for KRW 2,997.54 million under the buyback announced on December 2, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,390 KRW | -0.31% | -1.99% | -27.22% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.22% | 16Cr | |
+8.63% | 11TCr | |
+13.17% | 11TCr | |
-12.76% | 2.22TCr | |
-2.30% | 2.13TCr | |
-5.24% | 1.88TCr | |
-7.19% | 1.75TCr | |
-39.93% | 1.72TCr | |
+6.67% | 1.41TCr | |
+33.90% | 1.22TCr |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.